The promoters of Vivimed Labs have launched a new venture, Sanvita Biotech, with a vision to establish a strong presence in the veterinary vaccines market. Focused on addressing critical needs in animal health, the company is setting up its first state-of-the-art manufacturing facility in Sangareddy, near Hyderabad. This facility will initially produce and market vaccines for Foot and Mouth Disease (FMD), a significant concern in livestock health, followed by the introduction of vaccines for Rabies and other diseases.
Sanvita Biotech recently achieved a major milestone with the successful financial closure of $9 million in debt. Springforth Capital acted as the exclusive advisor for the transaction, securing funding from a leading nationalized bank. With this financial backing, the company aims to launch its products within 30 months.
The venture is supported by a robust operational and scientific team led by Chairman Dr. Manohar Rao, a Veterinary Science doctorate and the founder of Vivimed Labs.